Antiperspirant Duration Claim Restrictions Contested By CTFA
This article was originally published in The Tan Sheet
Executive Summary
Restricting enhanced duration claims under the OTC Antiperspirant Drug Products Final Monograph violates First Amendment principles and is inconsistent with FDA regulatory precedent, according to the Cosmetic, Toiletry & Fragrance Association
You may also be interested in...
Certain Dri Antiperspirant Study Supports 48-Hour Claims – Numark
Clinical testing by Numark Laboratories supports an "extra effective" enhanced duration claim for Certain Dri antiperspirant, according to the company
Certain Dri Antiperspirant Study Supports 48-Hour Claims – Numark
Clinical testing by Numark Laboratories supports an "extra effective" enhanced duration claim for Certain Dri antiperspirant, according to the company
Certain Dri Antiperspirant Study Supports 48-Hour Claims – Numark
Clinical testing by Numark Laboratories supports an "extra effective" enhanced duration claim for Certain Dri antiperspirant, according to the company